These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8299693)

  • 61. Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation.
    Warfel AH; Zucker-Franklin D; Frangione B; Ghiso J
    J Exp Med; 1987 Dec; 166(6):1912-7. PubMed ID: 3119764
    [TBL] [Abstract][Full Text] [Related]  

  • 62. When do human macrophages release nitric oxide? Variable effects of certain in vitro cultural and in vivo resident conditions.
    Wang CL; Su MH; Chao TY; Shaio MF; Yang KD
    Proc Natl Sci Counc Repub China B; 1996 Jul; 20(3):65-70. PubMed ID: 8956521
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human monocytes/macrophages: NO or no NO?
    Denis M
    J Leukoc Biol; 1994 May; 55(5):682-4. PubMed ID: 8182347
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential effects of human blood monocytes on the growth of human tumour cell lines in vitro.
    Parry HJ; Rees RC
    Cancer Immunol Immunother; 1992; 34(6):355-60. PubMed ID: 1563012
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Freshly harvested endothelial and mononuclear cells: comparison to cells in culture.
    Bing RJ; Dudek R; Conforto A
    In Vitro Cell Dev Biol Anim; 1993 May; 29A(5):353-5. PubMed ID: 8314728
    [No Abstract]   [Full Text] [Related]  

  • 66. Interactions between cytokines and nitric oxide.
    Liew FY
    Adv Neuroimmunol; 1995; 5(2):201-9. PubMed ID: 7496613
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines, but simultaneously stimulates C3 production.
    Høgåsen AK; Abrahamsen TG
    Thromb Res; 1995 Oct; 80(2):179-84. PubMed ID: 8588195
    [No Abstract]   [Full Text] [Related]  

  • 68. Gamma interferon modulation of prostaglandin E2 release from monocytes stimulated with lipopolysaccharides from Bacteroides intermedius, Bacteroides gingivalis, and Salmonella typhimurium.
    Garrison SW; Nichols FC
    Oral Microbiol Immunol; 1988 Sep; 3(3):138-43. PubMed ID: 3152029
    [No Abstract]   [Full Text] [Related]  

  • 69. Prenylated benzoic acid derivatives from Ferula kuhistanica.
    Chen B; Kawazoe K; Takaishi Y; Honda G; Itoh M; Takeda Y; Kodzhimatov OK; Ashurmetov O
    J Nat Prod; 2000 Mar; 63(3):362-5. PubMed ID: 10757719
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The studies on function of peripheral blood monocytes stimulated with lipopolysaccharide in liver disease].
    Higashimori T; Sakagami Y; Shiba T; Mizoguchi Y; Monna T; Yamamoto S; Morisawa S
    Nihon Shokakibyo Gakkai Zasshi; 1982 Jun; 79(6):1298-302. PubMed ID: 7131872
    [No Abstract]   [Full Text] [Related]  

  • 71. Nature and kinetics of redox imbalance triggered by respiratory and skin chemical sensitizers on the human monocytic cell line THP-1.
    Ferreira I; Silva A; Martins JD; Neves BM; Cruz MT
    Redox Biol; 2018 Jun; 16():75-86. PubMed ID: 29477863
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interferon regulatory factor (IRF)-1 is a master regulator of the cross talk between macrophages and L929 fibrosarcoma cells for nitric oxide dependent tumoricidal activity.
    Nascimento FR; Gomes EA; Russo M; Lepique AP
    PLoS One; 2015; 10(2):e0117782. PubMed ID: 25659093
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics.
    Finke JH; Rayman PA; Ko JS; Bradley JM; Gendler SJ; Cohen PA
    Cancer J; 2013; 19(4):353-64. PubMed ID: 23867518
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Properties of monocytes generated from haematopoietic CD34(+) stem cells from bone marrow of colon cancer patients.
    Stec M; Baran J; Szatanek R; Mytar B; Lenart M; Czupryna A; Szczepanik A; Siedlar M; Zembala M
    Cancer Immunol Immunother; 2013 Apr; 62(4):705-13. PubMed ID: 23180014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modulation of nitric oxide synthase activity in macrophages.
    Jorens PG; Matthys KE; Bult H
    Mediators Inflamm; 1995; 4(2):75-89. PubMed ID: 18475620
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tumour-associated macrophages and melanoma tumourigenesis: integrating the complexity.
    Hussein MR
    Int J Exp Pathol; 2006 Jun; 87(3):163-76. PubMed ID: 16709225
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enhancement of nitric oxide release in mouse inflammatory macrophages co-cultivated with tumor cells of a different origin.
    Calorini L; Bianchini F; Mannini A; Mugnai G; Ruggieri S
    Clin Exp Metastasis; 2005; 22(5):413-9. PubMed ID: 16283484
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dimerization of major histocompatibility complex class I on the surface of THP-1 cells stimulates the expression of inducible nitric oxide synthase and subsequent nitric oxide release.
    Bottley G; Fernández N
    Immunology; 2000 Aug; 100(4):449-54. PubMed ID: 10929071
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.
    Griffith TS; Wiley SR; Kubin MZ; Sedger LM; Maliszewski CR; Fanger NA
    J Exp Med; 1999 Apr; 189(8):1343-54. PubMed ID: 10209050
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity.
    Mytar B; Siedlar M; Wołoszyn M; Ruggiero I; Pryjma J; Zembala M
    Br J Cancer; 1999 Feb; 79(5-6):737-43. PubMed ID: 10070862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.